Letter to the editor: Comments on ‘A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation’

2020-10-01

Additional Metadata
Persistent URL	doi.org/10.1016/j.ejca.2020.07.014, hdl.handle.net/1765/129777
Journal	European Journal of Cancer
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Diekstra, F., Malmberg, R. (Ruben), Sleijfer, S., & van Leeuwen, R. (2020). Letter to the editor: Comments on ‘A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation’. European Journal of Cancer, 138, 54–56. doi:10.1016/j.ejca.2020.07.014

Publication